Tonix Pharmaceuticals Holding Corp. financial data

Symbol
TNXP on Nasdaq
Industry
Pharmaceutical Preparations
Location
26 Main Street, Suite 101, Chatham, NJ
State of incorporation
NV
Fiscal year end
December 31
Former names
TAMANDARE EXPLORATIONS INC. (to 10/17/2011)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 201 % -54.5%
Quick Ratio 56.6 %
Debt-to-equity 37.9 % +244%
Return On Equity -164 % -115%
Return On Assets -119 % -72.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 187M shares +684%
Common Stock, Shares, Outstanding 156M shares +776%
Entity Public Float 17M USD -66%
Common Stock, Value, Issued 156K USD +767%
Weighted Average Number of Shares Outstanding, Basic 62.1M shares +8478%
Weighted Average Number of Shares Outstanding, Diluted 62.1M shares +8478%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.82M USD -29.3%
Cost of Revenue 1.56M USD -34.5%
Research and Development Expense 48.8M USD -48.2%
General and Administrative Expense 29.9M USD +8.95%
Costs and Expenses 153M USD +19.6%
Operating Income (Loss) -142M USD -14.4%
Net Income (Loss) Attributable to Parent -135M USD -11.8%
Earnings Per Share, Basic 64.5 USD/shares +99.4%
Earnings Per Share, Diluted 64.5 USD/shares +99.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.2M USD +308%
Accounts Receivable, after Allowance for Credit Loss, Current 4.01M USD
Inventory, Net 7.93M USD -40.4%
Other Assets, Current 2.13M USD
Assets, Current 50.5M USD +61.3%
Property, Plant and Equipment, Net 42.7M USD
Operating Lease, Right-of-Use Asset 628K USD -41.9%
Intangible Assets, Net (Excluding Goodwill) 120K USD -98.8%
Goodwill 965K USD
Other Assets, Noncurrent 951K USD -9.52%
Assets 95M USD -31.8%
Accounts Payable, Current 3.94M USD -49.5%
Contract with Customer, Liability, Current 2.98M USD -8.95%
Liabilities, Current 15.2M USD -14.4%
Operating Lease, Liability, Noncurrent 425K USD -40.6%
Liabilities 20.8M USD +12.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -250K USD -13.6%
Retained Earnings (Accumulated Deficit) -709M USD -23.6%
Stockholders' Equity Attributable to Parent 74.2M USD -38.6%
Liabilities and Equity 95M USD -31.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.6M USD +46.6%
Net Cash Provided by (Used in) Financing Activities -212K USD +98.2%
Net Cash Provided by (Used in) Investing Activities -108K USD +97.2%
Common Stock, Shares Authorized 1B shares +525%
Common Stock, Shares, Issued 156M shares +776%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.9M USD +62.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29.1M USD +268%
Deferred Tax Assets, Valuation Allowance 45.5M USD +46.8%
Deferred Tax Assets, Gross 45.5M USD +46.8%
Operating Lease, Liability 700K USD -39.1%
Payments to Acquire Property, Plant, and Equipment 108K USD -97.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -135M USD -11.7%
Lessee, Operating Lease, Liability, to be Paid 763K USD -39.2%
Property, Plant and Equipment, Gross 46.3M USD -53.3%
Operating Lease, Liability, Current 275K USD -36.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 142K USD -52.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 299K USD -35%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 63K USD -39.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 139K USD -2.11%
Deferred Tax Assets, Operating Loss Carryforwards 33M USD +52.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD +1444%
Operating Lease, Payments 74K USD -46.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Depreciation, Depletion and Amortization 1.21M USD +35.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%